Table 2.
Outcome Measures
| Characteristic | Oral TXA group (n=94) | Control group (n=95) | p-value |
|---|---|---|---|
| Postoperative Hb (g/dL) | 11.9±1.4 | 11.2±1.3 | 0.001a) |
| Hb drop (g/dL) | 1.7±0.8 | 2.5±0.9 | <0.001a) |
| Drain (mL) | 154±77 | 203±77 | <0.001a) |
| Hidden blood loss (mL) | 244±193 | 423±270 | <0.001a) |
| Total blood loss (mL) | 398±186 | 626±265 | <0.001a) |
| Transfusion rate (%) | 1.06 | 3.16 | 0.621 |
| Length of stay (day) | 5.9±2.2 | 5.8±1.7 | 0.612 |
| Proximal DVT (%) | 1.1 | 0 | 0.497 |
| PE (%) | 1.1 | 1.1 | 1.000 |
| Infection (%) | 0 | 0 | - |
| Mortality (%) | 0 | 0 | - |
Values are presented as mean±standard deviation.
TXA: tranexamic acid, Hb: hemoglobin, DVT: deep vein thrombosis, PE: pulmonary embolism.
a)
p<0.05.